tiprankstipranks
Trending News
More News >
Spyre Therapeutics (SYRE)
NASDAQ:SYRE
US Market

Spyre Therapeutics (SYRE) Revenue

Compare
449 Followers

Spyre Therapeutics Revenue

Spyre Therapeutics had a revenue of 0.00 in the quarter ending Dec 31, 2024, with ―. This bring the company's revenue in the last twelve months to 0.00, Increased -100.00%. In the fiscal year ending Dec 31, 2024, Spyre Therapeutics had annual revenue of 0.00 with -100.00% growth.
Revenue (ttm)
0.00
Revenue Growth
-100.00%
P/S Ratio
Infinity
Revenue/Employee
$0
Employees
73
Market Cap
$904.70M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
0.00-886.00K-100.00%
Dec 31, 2023
886.00K-1.44M-61.96%
Dec 31, 2022
2.33M-16.41M-87.57%
Dec 31, 2021
18.74M+∞%
Dec 31, 2020
0.00
Dec 31, 2019
0.00-3.89M-100.00%
Dec 31, 2018
3.89M-1.32M-25.30%
Dec 31, 2017
5.21M577.00K+12.47%
Dec 31, 2016
4.63M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis